Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-03

Clinical Trial Update: Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effects of linagliptin on endothelial, renal, and retinal function in patients with hypertension and albuminuria; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tradjenta (Linagliptin)

Snippet

Sponsor: ikfe-CRO GmbH | Conditions: Arterial Hypertension, Albuminuria | Phase 3 | Status: COMPLETED